Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Traditional Chinese medicine effective part composition for treating primary glaucoma

A technology for primary glaucoma and effective parts, which can be used in drug combinations, medical preparations containing active ingredients, medical raw materials derived from arthropods, etc. Effect

Inactive Publication Date: 2014-05-07
广州市云桥生物科技有限公司
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine mostly adopts surgery and miotic drug treatment, but so far cannot make the already

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Ash tree 25g, oriental cattail 24g, honey 12g, ramie root 18g, lyepogon 15g and bergamot 6g, add 15 times the amount of water after drying, boil with strong fire, then decoct with water for 180min with slow fire, the obtained decoction is ready for use.

Embodiment 2

[0014] Clinical observation of 500 patients with primary glaucoma. All patients were diagnosed with primary glaucoma by clinical diagnosis. Take embodiment 1 gained decoction to patient, 1 day 2 times, take before meal sooner or later, continuous 25 days.

[0015] The statistical results of patients taking the decoction gained in Example 1 are shown in Table 1. Significant effect includes recovery and effectiveness. Recovery means visual acuity reaches 1.0 or more than 5 lines, intraocular pressure is normal, and other symptoms disappear; effective means visual acuity is improved by more than 3 lines, intraocular pressure drops by 10 mm Hg or more, and other symptoms are significantly improved. Ineffective means that after treatment, no significant change or insignificant change was seen in vision and intraocular pressure, and the symptoms did not improve.

[0016] Table 1

[0017] Number of cases markedly effective invalid Significant efficiency (%) 500...

Embodiment 3

[0020] The decoction prepared in Example 1 was used to administer ICR mice with a body weight of 20-25 g, half male and half female, and the administration was continued for 60 days.

[0021] After preliminary testing, the toxicity of the decoction prepared in Example 1 was very low, and the LD50 could not be detected, so the maximum daily dose was determined for mice. The maximum dosage is 400ml / d. After 60 days, there is no case of poisoning death, and all of them are healthy and alive. This proves that the decoction made from the composition of the present invention has no toxic side effects on the human body.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a traditional Chinese medicine effective part composition for treating primary glaucoma. The traditional Chinese medicine composition is prepared from the following raw materials in certain parts by weight: Chinese ash, typha orientalis, bee honey, ramie root, radix liriopes and fleshfingered citron flower. The traditional Chinese medicine effective part composition provided by the invention has the effects of dispelling wind and clearing heat, inducing dieresis and resolving phlegm, calming the adverse-rising energy and regulating vital energy, nourishing yin and suppressing yang, tonifying the liver and kidney, tonifying qi and activating blood, dispersing blood stasis and dredging collaterals, and warming liver and dispelling cold, has an obvious curative effect in treating primary glaucoma, has no side effects, and is high in safety.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine compositions, in particular to a composition of effective parts of traditional Chinese medicines for treating primary glaucoma. Background technique [0002] Glaucoma is a serious eye disease that causes optic disc depression, visual field defect, and eventually blindness due to elevated intraocular pressure. Clinically divided into primary, secondary and congenital three categories. Primary common. According to statistics, the incidence rate in my country is 0.89~2.6%, and the blindness rate reaches 19.62%. The onset of primary glaucoma, anatomical factors are the basic reasons, but emotional instability, fatigue, eye time transition, etc. are all inducing factors. Western medicine mostly adopts surgery and miotic drug treatment, but so far the optic nerve and visual function that have suffered organic damage cannot be restored again. Contents of the invention [0003] The objec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61P27/06A61K35/64A61K35/644
Inventor 张群
Owner 广州市云桥生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com